Moving toward improved immune checkpoint immunotherapy for advanced prostate cancer. De Velasco MA, Kura Y, Fujita K, Uemura H, et al. Int J Urol 2024 Jan 2. doi: 10.1111/iju.15378.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

De Velasco MA, Kura Y, Fujita K, Uemura H, et al. Moving toward improved immune checkpoint immunotherapy for advanced prostate cancer. Int J Urol 2024 Jan 2. doi: 10.1111/iju.15378.
PMID: 38167824